ACELRX PHARMACEUTICALS INC - COM (ACRX)

Historical Holders from Q1 2014 to Q2 2023

Type / Class
Equity / COM
Symbol
ACRX
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACELRX PHARMACEUTICALS INC - COM (ACRX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (% of par) Investors
2023 Q2 0 $0 -$4,068 0
2022 Q4 1,800 $4,068 -$3,876,208 226% 1
2022 Q3 18,232,940 $3,809,496 +$191,426 20.9% 48
2022 Q2 17,091,993 $4,177,130 -$690,252 24.49% 52
2022 Q1 19,842,878 $5,660,592 -$5,292,735 28.54% 44
2021 Q4 30,035,082 $16,822,135 +$5,007,578 56.02% 51
2021 Q3 20,068,142 $20,466,963 -$5,649,811 101.98% 55
2021 Q2 25,189,857 $34,763,488 -$15,692,890 138% 66
2021 Q1 36,212,313 $61,554,460 +$20,355,780 170% 80
2020 Q4 24,211,439 $30,025,933 +$1,947,504 123.98% 75
2020 Q3 22,607,510 $32,097,198 +$6,546,704 142% 69
2020 Q2 18,015,668 $21,790,722 -$1,307,830 120.78% 75
2020 Q1 19,106,783 $22,550,688 -$407,786 118.03% 66
2019 Q4 18,769,844 $39,587,964 -$120,544 210.72% 75
2019 Q3 18,451,014 $40,589,910 +$3,020,631 220% 64
2019 Q2 16,998,002 $42,995,000 +$9,985,055 253.03% 68
2019 Q1 12,219,253 $42,524,000 -$7,604,966 348% 67
2018 Q4 14,665,049 $33,884,000 +$16,320,971 230.88% 60
2018 Q3 6,668,697 $25,774,031 +$5,871,194 385.2% 54
2018 Q2 5,191,309 $17,519,415 +$3,453,199 337.48% 50
2018 Q1 4,308,273 $9,046,017 -$735,762 209.96% 41
2017 Q4 4,671,471 $9,476,016 -$11,188,478 202.53% 43
2017 Q3 6,896,581 $31,734,037 -$14,683,738 460% 51
2017 Q2 10,582,912 $22,750,017 -$7,283,689 214.96% 54
2017 Q1 13,672,126 $43,069,128 +$3,840,417 314.99% 64
2016 Q4 14,678,625 $38,187,488 -$2,781,197 260% 71
2016 Q3 15,723,867 $61,158,905 -$1,796,189 389% 60
2016 Q2 16,220,216 $43,629,382 +$972,348 269% 58
2016 Q1 15,497,014 $47,724,924 -$3,530,718 307.98% 58
2015 Q4 16,556,511 $63,770,155 -$298,850 385% 67
2015 Q3 16,765,425 $51,146,915 -$6,369,466 305% 54
2015 Q2 18,372,846 $77,900,192 -$11,704,132 424% 61
2015 Q1 21,212,373 $81,872,571 -$3,162,303 385.97% 71
2014 Q4 21,252,829 $143,019,250 +$5,586,842 673% 75
2014 Q3 20,660,351 $113,421,757 -$20,158,167 549% 80
2014 Q2 21,348,708 $218,818,451 -$30,727,481 1,025.01% 92
2014 Q1 24,088,181 $289,296,840 +$37,246,960 1,200.98% 90